These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. SCN5A channelopathies--an update on mutations and mechanisms. Zimmer T; Surber R Prog Biophys Mol Biol; 2008; 98(2-3):120-36. PubMed ID: 19027780 [TBL] [Abstract][Full Text] [Related]
7. Analyses of a novel SCN5A mutation (C1850S): conduction vs. repolarization disorder hypotheses in the Brugada syndrome. Petitprez S; Jespersen T; Pruvot E; Keller DI; Corbaz C; Schläpfer J; Abriel H; Kucera JP Cardiovasc Res; 2008 Jun; 78(3):494-504. PubMed ID: 18252757 [TBL] [Abstract][Full Text] [Related]
8. The occurrence of Brugada syndrome and isolated cardiac conductive disease in the same family could be due to a single SCN5A mutation or to the accidental association of both diseases. Six I; Hermida JS; Huang H; Gouas L; Fressart V; Benammar N; Hainque B; Denjoy I; Chahine M; Guicheney P Europace; 2008 Jan; 10(1):79-85. PubMed ID: 18156160 [TBL] [Abstract][Full Text] [Related]
9. Overlap syndrome of cardiac sodium channel disease in mice carrying the equivalent mutation of human SCN5A-1795insD. Remme CA; Verkerk AO; Nuyens D; van Ginneken AC; van Brunschot S; Belterman CN; Wilders R; van Roon MA; Tan HL; Wilde AA; Carmeliet P; de Bakker JM; Veldkamp MW; Bezzina CR Circulation; 2006 Dec; 114(24):2584-94. PubMed ID: 17145985 [TBL] [Abstract][Full Text] [Related]
11. A novel mutation in the SCN5A gene is associated with Brugada syndrome. Shin DJ; Kim E; Park SB; Jang WC; Bae Y; Han J; Jang Y; Joung B; Lee MH; Kim SS; Huang H; Chahine M; Yoon SK Life Sci; 2007 Jan; 80(8):716-24. PubMed ID: 17141278 [TBL] [Abstract][Full Text] [Related]
12. A novel C-terminal truncation SCN5A mutation from a patient with sick sinus syndrome, conduction disorder and ventricular tachycardia. Tan BH; Iturralde-Torres P; Medeiros-Domingo A; Nava S; Tester DJ; Valdivia CR; Tusié-Luna T; Ackerman MJ; Makielski JC Cardiovasc Res; 2007 Dec; 76(3):409-17. PubMed ID: 17897635 [TBL] [Abstract][Full Text] [Related]
13. Unconventional intronic splice site mutation in SCN5A associates with cardiac sodium channelopathy. Rossenbacker T; Schollen E; Kuipéri C; de Ravel TJ; Devriendt K; Matthijs G; Collen D; Heidbüchel H; Carmeliet P J Med Genet; 2005 May; 42(5):e29. PubMed ID: 15863661 [TBL] [Abstract][Full Text] [Related]
17. Sodium channelopathies: do we really understand what's going on? Postema PG; Mosterd A; Hofman N; Alders M; Wilde AA J Cardiovasc Electrophysiol; 2011 May; 22(5):590-3. PubMed ID: 20812931 [TBL] [Abstract][Full Text] [Related]
18. Clinical and electrophysiological characteristics of Brugada syndrome caused by a missense mutation in the S5-pore site of SCN5A. Itoh H; Shimizu M; Mabuchi H; Imoto K J Cardiovasc Electrophysiol; 2005 Apr; 16(4):378-83. PubMed ID: 15828879 [TBL] [Abstract][Full Text] [Related]
19. Mutational screening of SCN5A linked disorders in Polish patients and their family members. Moric-Janiszewska E; Herbert E; Cholewa K; Filipecki A; Trusz-Gluza M; Wilczok T J Appl Genet; 2004; 45(3):383-90. PubMed ID: 15306732 [TBL] [Abstract][Full Text] [Related]
20. A novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating. Wehrens XH; Rossenbacker T; Jongbloed RJ; Gewillig M; Heidbüchel H; Doevendans PA; Vos MA; Wellens HJ; Kass RS Hum Mutat; 2003 May; 21(5):552. PubMed ID: 12673799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]